Saudi Arabia’s Capital Market Authority announced that the Committee for Resolution of Securities Disputes (CRSD) has approved registration of an investor class action against members of the board of directors and audit committee of Middle East Healthcare Company (Saudi German Health). The action follows a final appeals ruling against the members for inflating the company’s revenues and creating a false and misleading impression of its book value.
The violations involved recognizing SAR 358,044,138 in unearned gross revenues despite the board and audit committee’s awareness of the low likelihood of collection. Incorrect information appeared in financial statements covering the financial year ended Dec. 31, 2018, through the interim period ended Sept. 30, 2021, affecting the company’s reported assets and misrepresenting its financial position.
Investors who purchased the company’s shares from March 24, 2019, and retained ownership through the close of trading on March 30, 2022, may apply to the CRSD to join the action within 90 days of the announcement. The eligibility cutoff precedes the company’s announcement of corrected financial statements on March 31, 2022.